(Q43196827)

15 November 2017

title

Significance of serum vascular endothelial growth factor level in patients with idiopathic pulmonary fibrosis (English)

1 reference

15 November 2017

1 reference

Masaru Ando

1

1 reference

15 November 2017

Eishi Miyazaki

2

1 reference

15 November 2017

Takeo Ito

3

1 reference

15 November 2017

Shigeo Hiroshige

4

1 reference

15 November 2017

Shin-ich Nureki

5

1 reference

15 November 2017

Takuya Ueno

6

1 reference

15 November 2017

Ryuichi Takenaka

7

1 reference

15 November 2017

Tetsujiro Fukami

8

1 reference

15 November 2017

Toshihide Kumamoto

9

1 reference

15 November 2017

publication date

12 January 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

188

1 reference

15 November 2017

issue

3

1 reference

15 November 2017

page(s)

247-252

1 reference

https://api.crossref.org/works/10.1007%2FS00408-009-9223-X

15 November 2017

1 reference

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-009-9223-X

Lung inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-009-9223-X

Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-009-9223-X

Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-009-9223-X

Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases

21 January 2018

1 reference

12 December 2020

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

1 reference

12 December 2020

The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis

1 reference

12 December 2020

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

1 reference

12 December 2020

Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1

1 reference

12 December 2020

Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells

1 reference

12 December 2020

Idiopathic pulmonary fibrosis: the inflammation hypothesis revisited

1 reference

12 December 2020

Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis

1 reference

12 December 2020

KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease

1 reference

12 December 2020

Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome

1 reference

12 December 2020

Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis

1 reference

12 December 2020

Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis.

1 reference

12 December 2020

Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis

1 reference

12 December 2020

Vascular-specific growth factors and blood vessel formation

1 reference

12 December 2020

Angiogenic cytokines in patients with idiopathic interstitial pneumonia

1 reference

12 December 2020

VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice

1 reference

12 December 2020

Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis

1 reference

12 December 2020

Idiopathic pulmonary fibrosis: predicting response to therapy and survival

1 reference

12 December 2020

Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease

1 reference

12 December 2020

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D

1 reference

12 December 2020

10.1007/S00408-009-9223-X

Identifiers

DOI

1 reference

15 November 2017

1 reference